miR766-3p and miR124-3p Dictate Drug Resistance and Clinical Outcome in HNSCC

SIMPLE SUMMARY: Despite improvements in therapeutics, head and neck squamous cell carcinomas (HNSCC) relapse in more than 50% of cases due to the development of chemo-radiotherapy resistance during sequential treatments. Our findings provide a strong rationale which can improve potential therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales: Shibata, Tomohiro, Cao, Duo-Yao, Dar, Tahir B., Ahmed, Faizan, Bhat, Shabir A., Veiras, Luciana C., Bernstein, Ellen A., Khan, Abdul Arif, Chaum, Manita, Shiao, Stephen L., Tourtellotte, Warren G., Giani, Jorge F., Bernstein, Kenneth E., Cui, Xiaojiang, Vail, Eric, Khan, Zakir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9655574/
https://www.ncbi.nlm.nih.gov/pubmed/36358691
http://dx.doi.org/10.3390/cancers14215273

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9655574/
https://www.ncbi.nlm.nih.gov/pubmed/36358691
http://dx.doi.org/10.3390/cancers14215273

Ejemplares similares